Overview
Mercury Laboratories Limited, established in 1962, is a pharmaceutical company specializing in medicinal drugs and formulations. Incorporated as a private limited company in 1982, it later transitioned to a publicly listed entity in 1992.
The company consistently generates profits and pays dividends, indicating robust financial health and shareholder value.
Mercury Laboratories has a long-standing presence in the pharmaceutical industry, highlighting its stability and experience.
The company's transformation from a partnership firm to a public limited company showcases strategic business development over the decades.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
91 Cr
- Volatility
Low Risk
- P/E Ratio
19.6
- Industry P/E
32.3
- PEG Ratio
—
- P/B Ratio
1.6
- 52W High
976.00
- 52W Low
700.00
Financial Ratios
Sales CAGR
- 1Y
- -0.61%
- 3Y
- 9.04%
- 5Y
- 5.57%
- 10Y
- 4.70%
Profit CAGR
- 1Y
- -44.42%
- 3Y
- -4.07%
- 5Y
- -0.52%
- 10Y
- -2.43%
ROE
- TTM
- 8.81%
- 3Y
- 9.58%
- 5Y
- 10.24%
- 10Y
- 10.53%
ROCE
- TTM
- 11.49%
- 3Y
- 12.35%
- 5Y
- 13.33%
- 10Y
- 13.65%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
